Welcome to the Loma Linda University Eye Institute Research Division, where we are deeply committed to enhancing eye health and fulfilling our mission of "making man whole" through pioneering research efforts. Our team tirelessly conducts clinical trials to expand treatment options and provide the most effective care for patients battling eye diseases.

Since 2004, we have been at the forefront of clinical research in Southern California's Inland Empire, gaining recognition as a leading clinical site. We offer participation in numerous studies addressing a wide range of eye conditions, led by our dedicated physicians who devote significant time to advancing new therapies.

Our dedication to innovation and community-driven research remains steadfast. We are proud to introduce our esteemed research team, led by Norlisha Borntrager, our Lead Coordinator, and supported by Rebecca Pereyra, who plays pivotal roles in facilitating our trials. Additionally, we are pleased to announce Wilson Mojica, a Spanish-speaking coordinator dedicated to serving the Spanish-speaking community.

Our purpose is to develop and apply knowledge that will improve the quality of life of patients suffering from ocular diseases through patient-centered and community-driven research. We continue to pursue innovative paths by dedicating ourselves to our community, to excellence, and to providing exceptional patient care.

With a strong commitment to medical research and the advancement of treatments for all conditions of eye diseases, we strive to be at the forefront of cutting-edge therapies. If you or someone you know is interested in more information about our clinical research trials in Ophthalmology, please contact us at 909-558-2233.

Elsevier Article

Elsevier Article

Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery
Read story